National Guidelines for IPC in HCF - final(1).pdf
1.8 MB
Emailing National Guidelines for IPC in HCF - final(1).pdf
COVIDWebinarSchedule26March2019.pdf.pdf
112.8 KB
Emailing COVIDWebinarSchedule26March2019.pdf.pdf
India-prediction-John Hopkins.pdf.pdf.pdf.pdf
6.8 MB
Emailing India-prediction-John Hopkins.pdf.pdf.pdf.pdf
GuidelinesonrationaluseofPersonalProtectiveEquipment.pdf
288 KB
Emailing GuidelinesonrationaluseofPersonalProtectiveEquipment.pdf
10.1001@jama.2020.3227.pdf
116 KB
Emailing 10.1001@jama.2020.3227.pdf
Mount_Sinai_Health_System_Treatment_Guidelines_for_COVID_UPDATED.pdf
661.6 KB
Emailing Mount Sinai Health System Treatment Guidelines for COVID UPDATED 3.18.2020.pdf.pdf.pdf
“Happy Doctor's Day to all the doctors who always put their patients first and do their best to gift health to their patients.”
https://t.me/joinchat/AAAAAEUcZMS1_8tEWgkCcQ
https://t.me/joinchat/AAAAAEUcZMS1_8tEWgkCcQ
https://medicaldialogues.in/medicine/news/fda-approves-first-ever-treatment-for-rare-rapid-aging-disease-progeria-71654#.X7i5U9ywxBI.telegram
FDA approves first ever treatment for Rare Rapid-Aging Disease Progeria
FDA approves first ever treatment for Rare Rapid-Aging Disease Progeria
medicaldialogues.in
FDA approves first ever treatment for Rare Rapid-Aging Disease Progeria
The US Food and Drug Administration (FDA) has approved lonafarnib (Zokinvy) capsules for the for the treatment of Progeria and processing-deficient Progeroid Laminopathies (PL).It has been